At a glance
ClinicalIndex Comparison RecordN/ACompleted· 433 enrolled
Drug / intervention
Shunt catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus
In Brief
An observational study evaluating Shunt catheter for Hydrocephalus. Completed, enrolled 433 participants across 8 sites in 6 countries.
Detailed Summary
The purpose of this Registry is to compare shunt/catheter-related infection rates among various shunt systems when used according to hospital standard of care to treat hydrocephalus.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHydrocephalus
CountriesCanada, China, Hong Kong, India, Singapore, United States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
First PostedJan 2006
Primary CompletionApr 2008
TodayJul 2026
First PostedJan 24, 2006
Enrollment StartJan 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.4 years ago
Interventions
Shunt catheterdevice
standard of care implantation of shunt (any brand). Subjects are followed for 90 days to obtain information about whether or not an infection occurred.